Seminars in Hematology
Volume 45 , Pages S25-S30 , April 2008

Monitoring Inhibitor Patients With the Right Assays

  • Trevor W. Barrowcliffe

      Affiliations

    • Corresponding Author InformationAddress correspondence to Trevor W. Barrowcliffe, MA, PhD, 3 Boulby Bank, Whitby, Y022 4AN, UK.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 STATEMENT OF CONFLICT OF INTEREST: Trevor Barrowcliffe has worked as a consultant for Novo Nordisk, on topics unrelated to the subject of this article.

PII: S0037-1963(08)00042-5

doi: 10.1053/j.seminhematol.2008.03.002

Seminars in Hematology
Volume 45 , Pages S25-S30 , April 2008

Article Tools

* Image Usage & Resolution